Mouse parenchymal liver cells in culture secrete a growth inhibitor for myeloma cells

被引:6
作者
Takahashi, M
Yokomuro, K
机构
[1] Nippon Medical School, Dept. of Microbiology and Immunology, Tokyo
[2] Nippon Medical School, Dept. of Microbiology and Immunology, Tokyo 113, 1-1-5, Sedagi, Bunkyo-ku
关键词
cytokines; growth inhibitor; myeloma cells; parenchymal liver cells;
D O I
10.1016/S0168-8278(96)80033-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Methods: Growth inhibitory activity in the conditioned medium of mouse parenchymal liver cells was examined in three strains of myeloma cells. Results: Two strains of myeloma cells were highly sensitive to a low concentration of mouse parenchymal liver cell derived growth inhibitor, whereas one strain was resistant to the same concentration. Interferon-alpha beta and transforming growth factor-beta activity were detected in mouse parenchymal liver cells, while interferon-gamma and tumor necrosis factor-alpha were not. The growth suppression exerted by mouse parenchymal liver cell derived growth inhibitor in the three myeloma strains was distinct from that exerted by transforming growth factor-beta, tumor necrosis factor-alpha, interferon-alpha beta and interferon-gamma. The mouse parenchymal liver cell derived growth inhibitor was eluted with a peak activity in the 18 kDa range and focused into pI values of 3.8-4.0, and it was lost when mouse parenchymal liver cells were treated with heat or trypsin. Conclusion: These results indicate that mouse parenchymal liver cell derived growth inhibitor differs from the well-characterized growth inhibitors, transforming growth factor-beta, tumor necrosis factor-alpha, interferon-alpha beta and interferon-gamma.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 19 条
[1]   THE LIVER AND IGA - IMMUNOLOGICAL, CELL BIOLOGICAL AND CLINICAL IMPLICATIONS [J].
BROWN, WR ;
KLOPPEL, TM .
HEPATOLOGY, 1989, 9 (05) :763-784
[2]   GROWTH MODULATORY EFFECTS OF A LIVER-DERIVED GROWTH INHIBITOR, TRANSFORMING GROWTH FACTOR-BETA-1, AND RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA, IN NORMAL AND NEOPLASTIC-CELLS [J].
CHAPEKAR, MS ;
HUGGETT, AC ;
THORGEIRSSON, SS .
EXPERIMENTAL CELL RESEARCH, 1989, 185 (01) :247-257
[3]   BIOLOGICALLY-ACTIVE PRODUCTS OF STIMULATED LIVER MACROPHAGES (KUPFFER CELLS) [J].
DECKER, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 192 (02) :245-261
[4]   REGULATION OF NITRIC-OXIDE PRODUCTION BY STIMULATED RAT KUPFFER CELLS [J].
GAILLARD, T ;
MULSCH, A ;
BUSSE, R ;
KLEIN, H ;
DECKER, K .
PATHOBIOLOGY, 1991, 59 (04) :280-283
[5]   REGULATION OF INTERLEUKIN-6 PRODUCTION IN HUMAN FETAL KUPFFER CELLS [J].
KUTTEH, WH ;
RAINEY, WE ;
CARR, BR .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 33 (05) :607-613
[6]   THE LIVER AND THE HEMATOLYMPHOID SYSTEM .1. THE REGULATION OF NYLON-PASSED SPLEEN-CELL PROLIFERATION BY ACTIVE FACTORS RELEASED FROM SYNGENEIC NONPARENCHYMAL LIVER-CELLS [J].
MABUCHI, A ;
KOMURO, T ;
SAIZAWA, T ;
SAKAMOTO, T ;
WATARI, E ;
YOKOMURO, K .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (04) :402-411
[7]  
Mabuchi Ayako, 1994, Journal of Nippon Medical School, V61, P120
[8]  
MANNING RJ, 1984, GASTROENTEROLOGY, V87, P173
[9]  
MCMAHON JB, 1986, CANCER RES, V46, P4665